NCT00650702View on ClinicalTrials.gov

Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
GlaucomaOcular Hypertension
Interventions
DRUG

Latanoprost-PPDS

Control of IOP compared to baseline for the low dose of Latanoprost-PPDS for 4 months or until loss of efficacy

DRUG

Latanoprost-PPDS

Control of IOP compared to baseline for the medium dose of Latanoprost-PPDS for 4 months or until loss of efficacy

DRUG

Latanoprost-PPDS

Control of IOP compared to baseline for the high dose of Latanoprost-PPDS for 4 months or until loss of efficacy

Trial Locations (8)

11563

Lynbrook

19148

Philadelphia

21014

Bel Air

27262

High Point

55404

Minneapolis

63131

St Louis

90701

Artesia

95815

Sacramento

Sponsors
All Listed Sponsors
lead

Mati Therapeutics Inc.

INDUSTRY

NCT00650702 - Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension | Biotech Hunter | Biotech Hunter